about
Germline SMARCA4 mutations in patients with ovarian small cell carcinoma of hypercalcemic type.The Novel Gene CRNDE Encodes a Nuclear Peptide (CRNDEP) Which Is Overexpressed in Highly Proliferating Tissues.The putative oncogene, CRNDE, is a negative prognostic factor in ovarian cancer patients.p19(INK4d) mRNA and protein expression as new prognostic factors in ovarian cancer patients.The significance of c.690G>T polymorphism (rs34529039) and expression of the CEBPA gene in ovarian cancer outcome.Ovarian small cell carcinoma of hypercalcemic type - evidence of germline origin and SMARCA4 gene inactivation. a pilot study.Prognosis of patients with BRCA1-associated ovarian carcinomas depends on TP53 accumulation status in tumor cells.rs495139 in the TYMS-ENOSF1 Region and Risk of Ovarian Carcinoma of Mucinous Histology
P50
Q35195271-CE880018-E5A9-4FC6-BD98-D23664B17B6DQ35632884-DEEEA3B0-A528-4DA6-860C-9CA7FF4A6F16Q36685531-061CA448-60E7-4EFB-8A41-14F2B0AB6D6AQ37589242-BA2B1EB4-DDEA-43CF-9651-07095E9C83E7Q37687176-42E0568D-AE9A-45E2-A6FD-DB8A0A0101E9Q43627377-6B480B75-29B0-47B6-89A7-39847971A5C2Q51018239-59622F50-5A82-41BC-B8DC-3DF11BBFE991Q56334023-59803D75-2F80-4F62-BAC9-152A4C297B68
P50
description
Pools wetenschapper
@nl
researcher ORCID ID = 0000-0002-6915-3334
@en
name
Agnieszka Podgorska
@ast
Agnieszka Podgorska
@en
Agnieszka Podgorska
@es
Agnieszka Podgorska
@nl
type
label
Agnieszka Podgorska
@ast
Agnieszka Podgorska
@en
Agnieszka Podgorska
@es
Agnieszka Podgorska
@nl
prefLabel
Agnieszka Podgorska
@ast
Agnieszka Podgorska
@en
Agnieszka Podgorska
@es
Agnieszka Podgorska
@nl
P106
P1153
55876509000
P31
P496
0000-0002-6915-3334